ko world reiter buy
messag today result provid evid strategi
drive top line work gain momentum long-term expect
compani achiev organ sale growth next year driven
innov global market share gain price power without sacrif margin
increas ep due higher sale growth
rais price target due mostli higher earn power
report result beat expect ep compar
estim consensu organ sale growth ahead
estim softer growth north america vs gs off-set
stronger volum growth bottl segment bigger driver profit upsid
due time certain sg expenditur push oper margin bp
model expect manag rais organ sale guidanc
year maintain ep growth guidanc rang
currency-neutr basi due margin stronger fx headwind smaller
contribut structur item previous expect posit thesi remain
unchang continu view lead beverag busi strong
acceler organ sale growth industry-lead oper margin
top line momentum push manag increas organ sale growth
guidanc year suggest sustain growth momentum expect
extend next year beyond model
support global market leadership highli profit carbon soft drink
rapid aggress global innov acquisit agenda strength global
bottl system domin on-premis pushback investor
growth come expens margin agre least
growth margin dilut think compani right thing help off-set
neg mix impact acquisit product launch primarili reduc pack size
leverag strong price power benefit growth high-margin csd
aggress global approach ceo jame quincey assess remain highli
aggress approach build total beverag compani evidenc
exampl april launch european countri plan
end year costa ready-to-drink coffe recent launch uk plan
expand countri upcom launch alcohol drink call lemon-
japan fall furthermor compani continu take market share csd
categori global strong growth zero sugar sugar variant volum
north america overal remain bit soft encourag csd perform well
good perform premium offer non-carbon portfolio
topo chico smartwat simpli
chang estim revis model consid sever put take
remaind year worth detail increas organ growth project
larg driven increas volum estim bottl segment expect
grow high-singl digit back half slower pace driven mostli smaller
contribut india expect organ sale growth
face tougher year-ago comparison especi emea latam benefit
roughli pt extra trade day term oper profit assum
growth come due pt fx headwind benefit
estim lower sg expens come back mostli
full-year maintain ep despit stronger sale growth due stronger
fx headwind reduc benefit structur item model
stronger organ sale growth drive higher ep oper margin
reach structur lower follow re-integr ccba
upsid potenti fx headwind stabil start next year
page analyst certif import disclosur
valuat risk
deriv previous price target given pe multipl ep
estim price target support dcf analysi
premium us stapl slightli ko trade two year
prior acquir cce
premium price given stronger organ growth
profil asset-light model
risk valuat
risk upsid given valuat buy rate
increas regul debat continu whether sugar next tobacco regul
attempt crack sweeten food beverag consum
continu purchas product maintain global volum growth consist rate
although rate slightli declin develop market although new york citi fail
previous pass sweeten beverag tax philadelphia success
along citi west coast potenti plant seed
geographi us may also see anoth futur attempt new york citi
declin global csd categori past year us csd volum
declin becom appar foreign countri press us cast
neg light csd amount sugar contain led neg
percept csd well spark health concern amongst gener public
increas concern sugar artifici sweeten could prove issu
larg portion portfolio attribut csd declin off-set
high growth nab segment comparison nab segment rel small
may abl continu withstand declin csd
lack focu manag distract compani process build total
beverag portfolio expand rapidli new categori geographi think
right thing order transform compani growth profil outlook given
rapidli chang consum landscap highlight risk manag becom
spread thin core busi most-profit csd categori could suffer addit
compani expand higher-growth lower-margin categori dilut
page analyst certif import disclosur
page analyst certif import disclosur
page analyst certif import disclosur
incom million except per erecastmar y-o-i growth cost good gross gross sell gener expens total oper sg oper oper y-o-i growth ebitda y-o-i growth interest interest incom expens pre-tax y-o-i growth incom tax incom cont ep cont y-o-i growth non-control net incom common ex disc ep common ex disc dilut share sale breakdown ex elim volum price organ sale acquisit extra week beverag
issu research report guggenheim secur llc guggenheim secur research analyst whose name appear report
herebi certifi view express report accur reflect research analyst person view subject
secur issuer discuss herein ii part research analyst compens directli indirectli relat specif
recommend view express research analyst
research analyst research associ receiv compens base upon variou factor includ qualiti research investor client
feedback guggenheim secur llc overal revenu includ invest bank revenu
guggenheim secur llc affili expect receiv intend seek compens invest bank servic
compani inc next month
pleas refer websit company-specif disclosur referenc report http //guggenheimsecur bluematrix com/sellside/
disclosur action disclosur inform also avail complianc madison avenu new york ny
rate price target histori coca-cola compani ko
creat bluematrix
rate price target histori inc
buy describ stock expect provid total return price appreci plu yield within period
neutral describ stock expect provid total return price appreci plu yield plu minu within
sell describ stock expect provid total neg return price appreci plu yield within period
creat bluematrix
page analyst certif import disclosur
